POMC and Cowden syndrome 1: The first studies demonstrated that somatostatin itself as well as its synthetic somatostatin receptor 2 agonist, i.e., octreotide, inhibited ACTH secretion in Nelson’s syndrome [55] and ectopic CS [56, 57].